{"id":"https://openalex.org/W2056976690","doi":"https://doi.org/10.1056/nejmoa011161","title":"Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy","display_name":"Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy","publication_year":2001,"publication_date":"2001-09-20","ids":{"openalex":"https://openalex.org/W2056976690","doi":"https://doi.org/10.1056/nejmoa011161","mag":"2056976690","pmid":"https://pubmed.ncbi.nlm.nih.gov/11565518"},"language":"en","primary_location":{"id":"doi:10.1056/nejmoa011161","doi":"https://doi.org/10.1056/nejmoa011161","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa011161","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa011161?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa011161?articleTools=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016263167","display_name":"Barry Morton Brenner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry M. Brenner","raw_affiliation_strings":["Renal Division, Brigham and Women's Hospital, Boston, MA 02115, USA. bbrenner@partners.org","Renal Division, Brigham and Women's Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Division, Brigham and Women's Hospital, Boston, MA 02115, USA. bbrenner@partners.org","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Renal Division, Brigham and Women's Hospital, Boston","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062670268","display_name":"Mark Emmanuel Cooper","orcid":"https://orcid.org/0000-0001-7785-2488","observed_orcids":["https://orcid.org/0000-0001-7785-2488"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mark E. Cooper","raw_affiliation_strings":["Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I165779595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045497276","display_name":"Dick de Zeeuw","orcid":"https://orcid.org/0000-0003-3434-7777","observed_orcids":["https://orcid.org/0000-0003-3434-7777"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Dick de Zeeuw","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Groningen, Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Groningen, Groningen, the Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111955832","display_name":"William F. Keane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802288015","display_name":"Hennepin County Medical Center","ror":"https://ror.org/01k7a6660","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802288015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William F. Keane","raw_affiliation_strings":["Department of Medicine, Hennepin County Medical Center, Minneapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Hennepin County Medical Center, Minneapolis","institution_ids":["https://openalex.org/I2802288015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078490088","display_name":"William E. Mitch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William E. Mitch","raw_affiliation_strings":["Renal Division, Emory University, Atlanta"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Division, Emory University, Atlanta","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109208822","display_name":"Hans\u2010Henrik Parving","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans-Henrik Parving","raw_affiliation_strings":["Steno Diabetes Center, Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023556434","display_name":"Giuseppe Remuzzi","orcid":"https://orcid.org/0000-0002-6194-3446","observed_orcids":["https://orcid.org/0000-0002-6194-3446"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Remuzzi","raw_affiliation_strings":["Laboratori Negri Bergamo, Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratori Negri Bergamo, Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002798653","display_name":"Steven M. Snapinn","orcid":"https://orcid.org/0000-0002-2961-8774","observed_orcids":["https://orcid.org/0000-0002-2961-8774"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven M. Snapinn","raw_affiliation_strings":["Merck Research Laboratories, Blue Bell, Pa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Blue Bell, Pa","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019380758","display_name":"Zhonxin Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhonxin Zhang","raw_affiliation_strings":["Merck Research Laboratories, Blue Bell, Pa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Blue Bell, Pa","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113632302","display_name":"Shahnaz Shahinfar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahnaz Shahinfar","raw_affiliation_strings":["Merck Research Laboratories, Blue Bell, Pa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Blue Bell, Pa","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":261.75,"has_fulltext":true,"cited_by_count":7512,"citation_normalized_percentile":{"value":1.0,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"345","issue":"12","first_page":"861","last_page":"869"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9089999794960022},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":1.0},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8309999704360962},{"id":"https://openalex.org/keywords/renin-angiotensin-system-blockade","display_name":"renin-angiotensin system blockade","score":0.9309999942779541},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9779999852180481},{"id":"https://openalex.org/keywords/kidney-disease-progression","display_name":"kidney disease progression","score":0.6290000081062317},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cardiovascular-morbidity-and-mortality","display_name":"cardiovascular morbidity and mortality","score":0.8970000147819519},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.9860000014305115},{"id":"https://openalex.org/keywords/serum-creatinine-doubling","display_name":"serum creatinine doubling","score":0.800000011920929},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9416216015815735},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.8696485757827759},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6033070683479309},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.5611481070518494},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.5590046644210815},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5520805716514587},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5386417508125305},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.4760201573371887},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4734503924846649},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4619816243648529},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.45687854290008545},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4465736746788025},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.42805734276771545},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.41251975297927856},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.3681716322898865},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3364730775356293},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.21734336018562317}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003401","descriptor_name":"Creatine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003401","descriptor_name":"Creatine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003401","descriptor_name":"Creatine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1056/nejmoa011161","doi":"https://doi.org/10.1056/nejmoa011161","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa011161","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa011161?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:11565518","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11565518","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Clinical Trial"},{"id":"pmh:oai:diposit.ub.edu:2445/122643","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2445/122643","pdf_url":null,"source":{"id":"https://openalex.org/S4306401653","display_name":"Dip\u00f2sit Digital de la Universitat de Barcelona (Universitat de Barcelona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I71999127","host_organization_name":"Universitat de Barcelona","host_organization_lineage":["https://openalex.org/I71999127"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Articles publicats en revistes (Ci\u00e8ncies Cl\u00edniques)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/ee9582e5-580d-44aa-91bf-3dcec31cea5e","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/ee9582e5-580d-44aa-91bf-3dcec31cea5e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brenner, BM, Cooper, ME, de Zeeuw, D, Keane, WF, Mitch, WE, Parving, HH, Remuzzi, G, Snapinn, SM, Zhang, ZX, Shahinfar, S & RENAAL Study Investigators 2001, 'Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy', New England Journal of Medicine, vol. 345, no. 12, pp. 861-869.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:recercat.cat:2072/311563","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2445/122643","pdf_url":null,"source":{"id":"https://openalex.org/S4306402147","display_name":"RECERCAT (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/ee9582e5-580d-44aa-91bf-3dcec31cea5e","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/ee9582e5-580d-44aa-91bf-3dcec31cea5e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"New England Journal of Medicine, 345(12), 861 - 869. MASSACHUSETTS MEDICAL SOC","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1056/nejmoa011161","doi":"https://doi.org/10.1056/nejmoa011161","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa011161","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa011161?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8700000047683716}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2056976690.pdf","grobid_xml":"https://content.openalex.org/works/W2056976690.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W180946569","https://openalex.org/W1580788756","https://openalex.org/W1604542334","https://openalex.org/W1965476867","https://openalex.org/W1966972471","https://openalex.org/W1979300931","https://openalex.org/W1983269730","https://openalex.org/W1986924251","https://openalex.org/W1998434576","https://openalex.org/W2003670762","https://openalex.org/W2004164169","https://openalex.org/W2016046345","https://openalex.org/W2032425666","https://openalex.org/W2044773944","https://openalex.org/W2055864845","https://openalex.org/W2059707463","https://openalex.org/W2069142242","https://openalex.org/W2087798038","https://openalex.org/W2138119952","https://openalex.org/W2147804563","https://openalex.org/W2203067263","https://openalex.org/W2298868338","https://openalex.org/W2312400976","https://openalex.org/W2312999996","https://openalex.org/W2413195481","https://openalex.org/W2468643698","https://openalex.org/W2469805673","https://openalex.org/W2585382523","https://openalex.org/W2615684303","https://openalex.org/W2993043209","https://openalex.org/W3021250193","https://openalex.org/W3041047318","https://openalex.org/W3147894994","https://openalex.org/W3156148333","https://openalex.org/W4210434051","https://openalex.org/W4242344507","https://openalex.org/W4251212943"],"related_works":["https://openalex.org/W2170369890","https://openalex.org/W1993110263","https://openalex.org/W2360268716","https://openalex.org/W1977955927","https://openalex.org/W2158577494","https://openalex.org/W2056149757","https://openalex.org/W2127324952","https://openalex.org/W2394078855","https://openalex.org/W1970767617","https://openalex.org/W2380309161"],"abstract_inverted_index":{"BACKGROUND:":[0],"Diabetic":[1],"nephropathy":[2],"is":[3],"the":[4,13,17,39,47,50,112,118,143,157,161,170,180,186,209,235,239,269],"leading":[5],"cause":[6],"of":[7,12,19,43,49,65,105,114,117,134,145,147,153,182,185,211,225,241,259],"end-stage":[8,123,196],"renal":[9,20,124,148,197,277],"disease.":[10,149],"Interruption":[11],"renin-angiotensin":[14],"system":[15],"slows":[16],"progression":[18,146],"disease":[21,198],"in":[22,54,70,87,156,169,220,234,279],"patients":[23,35,55,67,155,280],"with":[24,36,56,83,167,250,265,271,281],"type":[25,37,57,282],"1":[26],"diabetes,":[27],"but":[28,204],"similar":[29,233],"data":[30],"are":[31],"not":[32],"available":[33],"for":[34,102,244,268],"2,":[38],"most":[40],"common":[41],"form":[42],"diabetes.":[44],"We":[45],"assessed":[46],"role":[48],"angiotensin-II-receptor":[51],"antagonist":[52],"losartan":[53,76,158,251,266],"2":[58,283],"diabetes":[59,284],"and":[60,98,136,142,195,227,285,287],"nephropathy.":[61],"METHODS:":[62],"A":[63,151],"total":[64,152],"1513":[66],"were":[68],"enrolled":[69],"this":[71],"randomized,":[72],"double-blind":[73],"study":[74],"comparing":[75],"(50":[77],"to":[78,89,218],"100":[79],"mg":[80],"once":[81],"daily)":[82],"placebo,":[84],"both":[85],"taken":[86],"addition":[88],"conventional":[90],"antihypertensive":[91],"treatment":[92],"(calcium-channel":[93],"antagonists,":[94],"diuretics,":[95],"alpha-blockers,":[96],"beta-blockers,":[97],"centrally":[99],"acting":[100],"agents),":[101],"a":[103,115,132,183],"mean":[104],"3.4":[106],"years.":[107],"The":[108,213,223,257],"primary":[109,162],"outcome":[110],"was":[111,232,247,289],"composite":[113,133,224],"doubling":[116,184],"base-line":[119],"serum":[120,187],"creatinine":[121,188],"concentration,":[122],"disease,":[125],"or":[126],"death.":[127,212],"Secondary":[128],"end":[129,163],"points":[130],"included":[131],"morbidity":[135,226],"mortality":[137,228],"from":[138,229],"cardiovascular":[139,230],"causes,":[140],"proteinuria,":[141],"rate":[144,210,240],"RESULTS:":[150],"327":[154],"group":[159,172],"reached":[160],"point,":[164],"as":[165],"compared":[166],"359":[168],"placebo":[171],"(risk":[173,190,199,252],"reduction,":[174,191,200,253],"16":[175],"percent;":[176,193,202,255],"P=0.02).":[177],"Losartan":[178,274],"reduced":[179],"incidence":[181],"concentration":[189],"25":[192],"P=0.006)":[194],"28":[201],"P=0.002)":[203],"had":[205],"no":[206],"effect":[207],"on":[208],"benefit":[214],"exceeded":[215],"that":[216],"attributable":[217],"changes":[219],"blood":[221],"pressure.":[222],"causes":[231],"two":[236],"groups,":[237],"although":[238],"first":[242],"hospitalization":[243],"heart":[245],"failure":[246],"significantly":[248],"lower":[249],"32":[254],"P=0.005).":[256],"level":[258],"proteinuria":[260],"declined":[261],"by":[262],"35":[263],"percent":[264],"(P<0.001":[267],"comparison":[270],"placebo).":[272],"CONCLUSIONS:":[273],"conferred":[275],"significant":[276],"benefits":[278],"nephropathy,":[286],"it":[288],"generally":[290],"well":[291],"tolerated.":[292]},"counts_by_year":[{"year":2026,"cited_by_count":170},{"year":2025,"cited_by_count":232},{"year":2024,"cited_by_count":211},{"year":2023,"cited_by_count":248},{"year":2022,"cited_by_count":235},{"year":2021,"cited_by_count":240},{"year":2020,"cited_by_count":263},{"year":2019,"cited_by_count":204},{"year":2018,"cited_by_count":212},{"year":2017,"cited_by_count":233},{"year":2016,"cited_by_count":243},{"year":2015,"cited_by_count":250},{"year":2014,"cited_by_count":289},{"year":2013,"cited_by_count":289},{"year":2012,"cited_by_count":341}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}